Early effect of Roux-en-Y gastric bypass on insulin sensitivity and signaling

Surgery for Obesity and Related Diseases

Volumn 12, Issue 1, 2016, Pages 42-47

  Severino, Anna ^a   Castagneto Gissey, Lidia ^b   Raffaelli, Marco ^b   Gastaldelli, Amalia ^c   Capristo, Esmeralda ^a   Iaconelli, Amerigo ^a   Guidone, Caterina ^a   Callari, Cosimo ^b   Bellantone, Rocco ^b   Mingrone, Geltrude ^a,d,e  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Gastric bypass; Insulin sensitivity; Insulin signaling

Indexed keywords

INSULIN; PROTEIN KINASE B; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BARIATRIC SURGERY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FAT FREE MASS; FAT MASS; FEMALE; HUMAN; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MORBID OBESITY; MUSCLE BIOPSY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; ROUX EN Y GASTRIC BYPASS; ROUX Y ANASTOMOSIS; WEIGHT REDUCTION; WESTERN BLOTTING; BLOOD; FOLLOW UP; GASTRIC BYPASS SURGERY; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; METABOLISM; OBESITY, MORBID; PHYSIOLOGY; SIGNAL TRANSDUCTION; TIME FACTOR;

ADULT; BLOOD GLUCOSE; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; OBESITY, MORBID; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84959494212     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2015.06.005     Document Type: Article

References (26)

1. Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006;55(7):2025-31.
2. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. New Engl J Med 2012;336(17):1577-85.
3. Rao RS, Yanagisawa R, Kini S. Insulin resistance and bariatric surgery. Obes Rev 2012;13(4):316-28.
4. Dirksen C, Jørgensen NB, Bojsen-Møller KN, et al. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabe-tologia 2012;55(7):1890-901.
5. Curry TB, Roberts SK, Basu R, et al. Gastric bypass surgery is associated with near-normal insulin suppression of lipolysis in nondiabetic individuals. Am J Physiol Endocrinol Metab 2011;300(4):E746-51.
6. Bojsen-Møller KN, Dirksen C, Jørgensen NB, et al. Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass. Diabetes 2014;63 (5):1725-37.
7. de Weijer BA, Aarts E, Janssen IM, et al. Hepatic and peripheral insulin sensitivity do not improve 2 weeks after bariatric surgery. Obesity (Silver Spring) 2013;21(6):1143-7.
8. Dunn JP, Abumrad NN, Breitman I, et al. Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy. Diabetes Care 2012;35(1):137-42.
9. Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 2000;106(2):165-9.
10. Leto D, Saltiel AR. Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol 2012;13(6):383-96.
11. Stephens L, Anderson K, Stokoe D, et al. Protein kinase B kinases that mediate phosphatidylinositol 3, 4, 5-trisphosphate-dependent activation of protein kinase B. Science 1998;279(5351):710-4.
12. Alessi DR, James SR, Downes CP, et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 1997;7(4):261-9.
13. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012;149(2):274-93.
14. Zoncu R, Sabatini DM, Efeyan A. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011;12(1):21-35.
15. Khamzina L, Veilleux A, Bergeron S, Marette A. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 2005;146(3):1473-81.
16. Kim SJ, DeStefano MA, Oh WJ, et al. mTOR complex 2 regulates proper turnover of insulin receptor substrate-1 via the ubiquitin ligase subunit Fbw8. Mol Cell 2012;48(6):875-87.
17. Gual P, Le Marchand-Brustel Y, Tanti JF. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 2005;87(1):99-109.
18. De Fronzo RA, Tobin JD, Andres R. Glucose clamp technique: a model for quantifying insulin secretion and resistance. Am J Physiol 1979;237(3):E214-23.
19. Jeon YH, Park YH, Kwon JH, Lee JH, Kim IY. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W. Biochim Biophys Acta. 2013;1833 (10):2135-42.
20. Knuefermann C, Lu Y, Liu B, et al. HER2/PI-3 K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells. Oncogene 2003;22(21):3205-12.
21. Scrima M, De Marco C, Fabiani F, et al. Signaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): new insights on the role of phosphatydil-inositol-3 kinase. PLoS One 2012;7(2):e30427.
22. Cybulskia N, Polaka P, Auwerxb J, et al. mTOR complex 2 in adipose tissue negatively controls whole-body growth. Proc Natl Acad Sci U S A 2009;106(24):9902-7.
23. Salinari S, Debard C, Bertuzzi A, et al. Jejunal proteins secreted by db/db mice or insulin-resistant humans impair the insulin signaling and determine insulin resistance. PLoS ONE 2013;8(2):e56258.
24. Bojsen-Møller KN, Dirksen C, Jørgensen NB, et al. Increased hepatic insulin clearance after Roux-en-Y gastric bypass. J Clin Endocrinol Metab 2013;98(6):E1066-71.
25. Castillo MJ, Scheen AJ, Letiexhe MR, Lefèbvre PJ. How to measure insulin clearance. Diabetes Metab Rev 1994;10(2):119-50.
26. Poy MN, Yang Y, Rezaei K, et al. CEACAM1 regulates insulin clearance in liver. Nat Genet 2002;30(3):270-6.